We have data on 38 companies that use Voyant TraumaCad. The companies using Voyant TraumaCad are most often found in United States and in the Hospital & Health Care industry. Voyant TraumaCad is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for Voyant TraumaCad usage goes back as far as 5 years and 11 months.
|Company||Intellijoint Surgical Inc.|
|Company||GUTHRIE THEATER FOUNDATION|
|Company||University of Virginia-Main Campus|
|Intellijoint Surgical Inc.||intellijointsurgical.com||Canada||1M-10M||50-200|
|GUTHRIE THEATER FOUNDATION||guthrietheater.org||United States||50M-100M||1000-5000|
|Banner Health||bannerhealth.com||United States||>1000M||>10000|
|University of Virginia-Main Campus||virginia.edu||United States||>1000M||>10000|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, Voyant TraumaCad has a market share of about 0.1%. Other major and competing products in this category include:
TraumaCad, is a surgical planning solution, which allows surgeons to replicate every action currently performed by tracing on x-ray films, only more conveniently and much faster. TraumaCad is installed at over 1, 000 locations in ten countries, including hospitals, clinics and academic institutions.
Looking at Voyant TraumaCad customers by industry, we find that Hospital & Health Care (53%), Medical Devices (11%) and Health, Wellness and Fitness (6%) are the largest segments.
71% of Voyant TraumaCad customers are in United States and 8% are in United Kingdom.
Of all the customers that are using Voyant TraumaCad, a majority (56%) are large (>1000 employees), 12% are small (<50 employees) and 17% are medium-sized.
Of all the customers that are using Voyant TraumaCad, a majority (50%) are large (>$1000M), 25% are small (<$50M) and 6% are medium-sized.